Apimeds Pharmaceuticals US APUS
NYSE APUS
$2.92 -0.24 (-7.44%)
As of: Oct 23, 2026 · 3:57 PM EDT

Apimeds Pharmaceuticals US (APUS) Cash & Current Investments (2023 - 2026)

Updated

Apimeds Pharmaceuticals US's Cash & Current Investments was $278,371 in Q2 2026, down 96.8% from $8.74 million a year earlier.

Analysis

Apimeds Pharmaceuticals US (APUS) Cash & Current Investments (2023 - 2026) Analysis & Trends

At the end of FY2025, Cash & Current Investments at Apimeds Pharmaceuticals US came in at $3.64 million.

  • In earlier years, Cash & Current Investments was $3,455 in FY2024 (-99.2%) and $410,481 in FY2023.
  • The Q2 2026 figure marks the lowest quarterly Cash & Current Investments since Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 17.23 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 6.57 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 11.70 Bn
10 Apimeds Pharmaceuticals US 4.97 Mn -14.67 Mn - 278,371.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 278,371.00
Dec 31, 2025 3.64 Mn
Sep 30, 2025 6.99 Mn
Jun 30, 2025 8.74 Mn
Mar 31, 2025 250,342.00
Dec 31, 2024 3,455.00
Dec 31, 2023 410,481.00
API Access

Apimeds Pharmaceuticals US Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=APUS&period=max&api_key=YOUR_API_KEY